Description
Important note: this is a standard peptide vial and will only hold a maximum of about 3.5mL of bacteriostatic water.
Each vial contains 60mg of highly pure Retatrutide.
Retatrutide is an investigational peptide classified as a triple receptor agonist that targets GLP-1, GIP, and glucagon (GCGR) receptors. This multi-pathway action is designed to enhance metabolic regulation, reduce appetite, and increase energy expenditure.
Compared to earlier GLP-1–based treatments like semaglutide, retatrutide is being studied for its potential to produce greater reductions in body fat by engaging additional metabolic pathways.
Reconstitution
Add 3mL of bacteriostatic water to get a solution that is 20mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 2mg of Retatrutide.
Storage
This product must be refrigerated after reconstitution.
